“We handled the storm pretty well,” says Newburgh Town Manager Chris Cooke. “Took a big hit here in the town, lost a lot of internet, lost a lot of utilities, and we’re working with our ...

Or sign-in if you have an account. In Jasper on Fire: Five Days of Hell in a Rocky Mountain Paradise, journalist Matthew Scace delivers a gripping account of a town under siege by nature’s most ...

Morecambe have signed midfielder Callum Cooke on a deal until the end of the season. Cooke was a free agent having left National League Hartlepool United at the end of last season. The 27-year-old ...

Add the Cooke clan from the village of Blacks Harbour to the Irvings and McCains on the list of New Brunswick entrepreneurs who have built global companies, while keeping it all in the family.

Working with your significant other isn’t always easy. Just ask Amanda Batula. “It’s our dream to be successful, but Loverboy is your thing, it’s your baby,” she explained. “I still ...

Alberta's federal bete noire is seen as the man with the power to secure Jasper's future after devastating wildfire. 'It's not going well' You can save this article by registering for free here.

As blazes continue to burn in L.A., Albertans know all-too-well the damage and misery that such massive walls of fire bring, including most recently July’s Jasper wildfire, and the behemoth Fort ...

On Wednesday, Jasper Therapeutics, Inc. JSPR reported preliminary data from the ongoing BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with chronic spontaneous ...

A U.S. District Court judge in Manhattan dismissed a case against Cooke Seafood Inc. and its subsidiaries and affiliates that alleged it defrauded the U.S. in the operation of its East Coast ...

Saint John-based Cooke Inc. was sued last July for its involvement in the menhaden fishery in Virginia. The lawsuit alleged Cooke knowingly defrauded the U.S. government by creating shell ...

Investing.com -- Shares of Jasper Therapeutics, Inc. (Nasdaq: JSPR) plummeted over 40% following the release of data from its BEACON study of Briquilimab in Chronic Spontaneous Urticaria (CSU).